Literature DB >> 19923903

Self-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells.

Direna Alonso-Curbelo1, María S Soengas.   

Abstract

Patients with metastatic melanoma have a poor prognosis, primarily due to a generalized inefficacy of current anticancer treatments. Therefore, the identification of novel death inducers with good bioavailability and safety profiles is a main priority in this disease. Here we summarize recent work from our group uncovering an unexpected ability of the dsRNA mimic polyinosine-polycytidylic acid (pIC) to engage the endo/lysosomal machinery of melanoma cells and induce their self degradation by autophagy and apoptosis, without noticeable secondary effects in vivo. However the antimelanoma activity of pIC strictly required conjugation with carriers (e.g., polyethyleneimine, PEI) for cytosolic delivery. Combining transcriptome analyses with RNA interference, we found RNA helicase MDA-5 as a main driver of the pIC-PEI complex. MDA-5 in turn, favored NOXA-dependent activation of apoptotic caspases. These results demonstrate new therapeutically tractable links between autophagy and apoptosis that can be coordinately engaged in tumor cells by dsRNA mimics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19923903     DOI: 10.4161/auto.6.1.10464

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  8 in total

1.  Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.

Authors:  Sara Palchetti; Donatella Starace; Paola De Cesaris; Antonio Filippini; Elio Ziparo; Anna Riccioli
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 2.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

3.  Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

Authors:  T Tomic; T Botton; M Cerezo; G Robert; F Luciano; A Puissant; P Gounon; M Allegra; C Bertolotto; J-M Bereder; S Tartare-Deckert; P Bahadoran; P Auberger; R Ballotti; S Rocchi
Journal:  Cell Death Dis       Date:  2011-09-01       Impact factor: 8.469

4.  Inflammatory signaling compromises cell responses to interferon alpha.

Authors:  W-C Huangfu; J Qian; C Liu; J Liu; A E Lokshin; D P Baker; H Rui; S Y Fuchs
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

5.  Routing cancer immunology and immunotherapy from the lab to the clinic 4-5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain.

Authors:  M Ángela Aznar; Ignacio Melero; José I Quetglas
Journal:  J Transl Med       Date:  2014-07-24       Impact factor: 5.531

6.  Immunotherapeutic effects of intratumoral nanoplexed poly I:C.

Authors:  M Angela Aznar; Lourdes Planelles; Mercedes Perez-Olivares; Carmen Molina; Saray Garasa; Iñaki Etxeberría; Guiomar Perez; Inmaculada Rodriguez; Elixabet Bolaños; Pedro Lopez-Casas; Maria E Rodriguez-Ruiz; Jose L Perez-Gracia; Ivan Marquez-Rodas; Alvaro Teijeira; Marisol Quintero; Ignacio Melero
Journal:  J Immunother Cancer       Date:  2019-05-02       Impact factor: 13.751

7.  Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.

Authors:  David Olmeda; Daniela Cerezo-Wallis; Cynthia Mucientes; Tonantzin G Calvo; Estela Cañón; Direna Alonso-Curbelo; Nuria Ibarz; Javier Muñoz; José L Rodriguez-Peralto; Pablo Ortiz-Romero; Sagrario Ortega; María S Soengas
Journal:  EMBO Mol Med       Date:  2021-11-11       Impact factor: 12.137

8.  Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles.

Authors:  Li Chen; Yunfei Ding; Yongzhong Wang; Xingrong Liu; Rj Babu; Wr Ravis; Weili Yan
Journal:  Int J Nanomedicine       Date:  2013-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.